How were Tribute Pharmaceuticals Canada's earnings last quarter?

Tribute Pharmaceuticals Canada Inc. (OTCMKTS:TBUFF) issued its quarterly earnings results on Monday, March, 31st. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The business had revenue of $2.90 million for the quarter.

How do I buy shares of Tribute Pharmaceuticals Canada?

Shares of TBUFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TBUFF

Tribute Pharmaceuticals Canada (TBUFF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free TBUFF Stock Alerts

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 50,100 shs
Average Volume: 71,826 shs
Market Capitalization: $105.76 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Tribute Pharmaceuticals Canada alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Tribute Pharmaceuticals Canada Stock (OTCMKTS:TBUFF)

Tribute Pharmaceuticals Canada Inc., formerly Stellar Pharmaceuticals Inc., is a Canadian pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada. The Company targets several therapeutic areas in Canada but has a particular interest in products for the treatment of pain, urology, dermatology and endocrinology/cardiology. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. On December 1, 2011, it acquired 100% of Tribute Pharmaceuticals Canada Ltd. and Tribute Pharma Canada Inc. As of December 31, 2011, its portfolio of assets includes nine products: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, and MycoVa. It has licensed BladderChek for the Canadian market from Inverness Medical Innovations North America, Inc. It eveloped Uracyst, a sterile 2 % sodium chondroitin sulfate solution available in a 20 milliliter vial.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

TBUFF Stock News Headlines

May 2, 2023 | yahoo.com

When her brother died, she wrote a moving tribute on a frisbee. Now, his memory is being shared from one city to the next.

April 27, 2023 | finance.yahoo.com

MITSUBISHI TANABE PHARMA CANADA RECEIVES ENGAGEMENT LETTER FROM PAN-CANADIAN PHARMACEUTICAL ALLIANCE FOR RADICAVA® ORAL SUSPENSION

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 21, 2023 | mirror.co.uk

Kate Middleton pays tribute to 'incredibly sad' William as they mark St Patrick's Day

October 16, 2022 | bbc.co.uk

Queen Elizabeth II: Boats, tugs and ferries take part in Mersey tribute

October 4, 2022 | mirror.co.uk

Liz Truss pays tribute to Queen in 'passing of second Elizabethan age - speech in full

October 3, 2022 | bbc.co.uk

Friends and colleagues pay tribute to Bill Turnbull

September 18, 2022 | investing.com

Tribute Pharmaceuticals Canada Inc (TRX)

See More Headlines

Receive TBUFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tribute Pharmaceuticals Canada and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/31/2014
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: OTCMKTS:TBUFF
CUSIP: N/A
CIK: N/A
Web: www.tributepharma.ca
Phone: +1-905-8761118
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 113,720,000
Free Float: N/A
Market Cap: $105.76 million
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Arnold Tenney (Age 70)
Chairman of the Board
Robert Harris (Age 57)
President, Chief Executive Officer, Director
Scott Langille (Age 56)
Chief Financial Officer, Director
Janice M. Clarke (Age 52)
Vice President - Finance and Administration
Steven H. Goldman (Age 57)
Independent Director
John M. Gregory (Age 60)
Independent Director
John J. Kime (Age 70)
Independent Director
Francis Martin Thrasher (Age 61)
Independent Director

TBUFF Stock Analysis - Frequently Asked Questions

How were Tribute Pharmaceuticals Canada's earnings last quarter?: Tribute Pharmaceuticals Canada Inc. (OTCMKTS:TBUFF) issued its quarterly earnings results on Monday, March, 31st. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The business had revenue of $2.90 million for the quarter.
How do I buy shares of Tribute Pharmaceuticals Canada?: Shares of TBUFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TBUFF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tribute Pharmaceuticals Canada (TBUFF) Stock Price, News & Analysis

About Tribute Pharmaceuticals Canada Stock (OTCMKTS:TBUFF)

TBUFF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

TBUFF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info